Bausch + Lomb Corporation (BLCO) Stock Forecast & Price Target

Compare

148 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BLCO Analyst Ratings

Hold

4 Buy

7 Hold

1 Sell

Based on 12 analysts giving stock ratings to

Bausch

+ Lomb Corporation

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BLCO Stock 12 Month Forecast

Average Price Target

$18.82

▲(4.90% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Bausch + Lomb Corporation in the last 3 months. The average price target is $18.82 with a high forecast of $21.00 and a low forecast of $15.00. The average price target represents a 4.90% change from the last price of $17.94.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","13":"$13","16":"$16","19":"$19","22":"$22"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$21.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.81818181818182,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$18.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,13,16,19,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.77,17.095384615384614,17.42076923076923,17.746153846153845,18.071538461538463,18.396923076923077,18.72230769230769,19.04769230769231,19.373076923076923,19.698461538461537,20.023846153846154,20.34923076923077,20.674615384615386,{"y":21,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.77,16.927552447552447,17.085104895104894,17.242657342657342,17.40020979020979,17.557762237762237,17.715314685314684,17.872867132867135,18.030419580419583,18.18797202797203,18.345524475524478,18.503076923076925,18.660629370629373,{"y":18.81818181818182,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.77,16.633846153846154,16.497692307692308,16.361538461538462,16.225384615384616,16.08923076923077,15.953076923076923,15.816923076923077,15.680769230769231,15.544615384615385,15.408461538461538,15.272307692307692,15.136153846153846,{"y":15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.35,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.1,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.59,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.81,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.67,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.94,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.56,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.08,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.77,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$21.00

Average Price Target$18.82

Lowest Price Target$15.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Yi Chen

H.C. Wainwright

$17→$20

Buy

11.48%

Upside

Reiterated

02/23/26

Bausch + Lomb price target raised to $20 from $17 at H.C. WainwrightBausch + Lomb price target raised to $20 from $17 at H.C. Wainwright

Pito Chickering

Deutsche Bank

$15→$18

Hold

0.33%

Upside

Reiterated

02/19/26

Bausch + Lomb price target raised to $18 from $15 at Deutsche BankBausch + Lomb price target raised to $18 from $15 at Deutsche Bank

Matt Miksic

Barclays

$17→$20

Hold

11.48%

Upside

Reiterated

02/19/26

Bausch + Lomb price target raised to $20 from $17 at BarclaysBausch + Lomb price target raised to $20 from $17 at Barclays

Joanne Wuensch

Citi

$20→$21

Buy

17.06%

Upside

Reiterated

02/19/26

Bausch + Lomb price target raised to $21 from $20 at CitiBausch + Lomb price target raised to $21 from $20 at Citi

Travis Steed

Bank of America Securities

$15

Sell

-16.39%

Downside

Reiterated

02/19/26

Maintaining Sell: Structural Overhangs and Margin Shortfalls Overshadow Bausch + Lomb’s Growth Story

Douglas Miehm

RBC Capital

$21

Buy

17.06%

Upside

Reiterated

02/19/26

Analysts' Top Healthcare Picks: Bausch + Lomb Corporation (BLCO), Insulet (PODD)

Thomas Stephan

Stifel Nicolaus

$15→$16

Hold

-10.81%

Downside

Reiterated

02/19/26

Stifel Nicolaus Keeps Their Hold Rating on Bausch + Lomb Corporation (BLCO)

Larry Biegelsen

Wells Fargo

$17→$18

Hold

0.33%

Upside

Reiterated

02/19/26

Bausch + Lomb Corporation (BLCO) Receives a Hold from Wells Fargo

David Saxon

Needham

―

Hold

―

Reiterated

02/18/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: ImmunityBio (NASDAQ: IBRX) and Bausch + Lomb Corporation (NYSE: BLCO)

David Roman

Goldman Sachs

$17→$19

Hold

5.91%

Upside

Reiterated

01/09/26

Bausch + Lomb price target raised to $19 from $17 at Goldman SachsBausch + Lomb price target raised to $19 from $17 at Goldman Sachs

Vijay Kumar

Evercore ISI

$18

Hold

0.33%

Upside

Downgraded

01/05/26

Bausch + Lomb downgraded to In Line from Outperform at Evercore ISIBausch + Lomb downgraded to In Line from Outperform at Evercore ISI

Patrick Wood

Morgan Stanley

$21

Buy

17.06%

Upside

Upgraded

12/03/25

Bausch + Lomb upgraded to Overweight from Equal Weight at Morgan StanleyBausch + Lomb upgraded to Overweight from Equal Weight at Morgan Stanley

Robbie Marcus

J.P. Morgan

$13→$16

Hold

-10.81%

Downside

Reiterated

10/30/25

Bausch + Lomb price target raised to $16 from $13 at JPMorganBausch + Lomb price target raised to $16 from $13 at JPMorgan

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Yi Chen

H.C. Wainwright

$17→$20

Buy

11.48%

Upside

Reiterated

02/23/26

Bausch + Lomb price target raised to $20 from $17 at H.C. WainwrightBausch + Lomb price target raised to $20 from $17 at H.C. Wainwright

Pito Chickering

Deutsche Bank

$15→$18

Hold

0.33%

Upside

Reiterated

02/19/26

Bausch + Lomb price target raised to $18 from $15 at Deutsche BankBausch + Lomb price target raised to $18 from $15 at Deutsche Bank

Matt Miksic

Barclays

$17→$20

Hold

11.48%

Upside

Reiterated

02/19/26

Bausch + Lomb price target raised to $20 from $17 at BarclaysBausch + Lomb price target raised to $20 from $17 at Barclays

Joanne Wuensch

Citi

$20→$21

Buy

17.06%

Upside

Reiterated

02/19/26

Bausch + Lomb price target raised to $21 from $20 at CitiBausch + Lomb price target raised to $21 from $20 at Citi

Travis Steed

Bank of America Securities

$15

Sell

-16.39%

Downside

Reiterated

02/19/26

Maintaining Sell: Structural Overhangs and Margin Shortfalls Overshadow Bausch + Lomb’s Growth Story

Douglas Miehm

RBC Capital

$21

Buy

17.06%

Upside

Reiterated

02/19/26

Analysts' Top Healthcare Picks: Bausch + Lomb Corporation (BLCO), Insulet (PODD)

Thomas Stephan

Stifel Nicolaus

$15→$16

Hold

-10.81%

Downside

Reiterated

02/19/26

Stifel Nicolaus Keeps Their Hold Rating on Bausch + Lomb Corporation (BLCO)

Larry Biegelsen

Wells Fargo

$17→$18

Hold

0.33%

Upside

Reiterated

02/19/26

Bausch + Lomb Corporation (BLCO) Receives a Hold from Wells Fargo

David Saxon

Needham

―

Hold

―

Reiterated

02/18/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: ImmunityBio (NASDAQ: IBRX) and Bausch + Lomb Corporation (NYSE: BLCO)

David Roman

Goldman Sachs

$17→$19

Hold

5.91%

Upside

Reiterated

01/09/26

Bausch + Lomb price target raised to $19 from $17 at Goldman SachsBausch + Lomb price target raised to $19 from $17 at Goldman Sachs

Vijay Kumar

Evercore ISI

$18

Hold

0.33%

Upside

Downgraded

01/05/26

Bausch + Lomb downgraded to In Line from Outperform at Evercore ISIBausch + Lomb downgraded to In Line from Outperform at Evercore ISI

Patrick Wood

Morgan Stanley

$21

Buy

17.06%

Upside

Upgraded

12/03/25

Bausch + Lomb upgraded to Overweight from Equal Weight at Morgan StanleyBausch + Lomb upgraded to Overweight from Equal Weight at Morgan Stanley

Robbie Marcus

J.P. Morgan

$13→$16

Hold

-10.81%

Downside

Reiterated

10/30/25

Bausch + Lomb price target raised to $16 from $13 at JPMorganBausch + Lomb price target raised to $16 from $13 at JPMorgan

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bausch + Lomb Corporation

3 Months

xxx

Success Rate

16/26 ratings generated profit

Average Return

+2.38%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +2.38% per trade.

1 Year

Douglas MiehmRBC Capital

Success Rate

16/26 ratings generated profit

Average Return

+5.14%

a rating ―

Copying Douglas Miehm's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +5.14% per trade.

2 Years

xxx

Success Rate

15/26 ratings generated profit

Average Return

+6.27%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 57.69% of your transactions generating a profit, with an average return of +6.27% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BLCO Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BLCO has received 7 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. BLCO average Analyst price target in the past 3 months is 18.82.

Each month's total comprises the sum of three months' worth of ratings.

BLCO Financial Forecast

BLCO Earnings Forecast

Next quarter’s earnings estimate for BLCO is $0.05 with a range of $0.02 to $0.17. The previous quarter’s EPS was $0.32. BLCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year BLCO has Performed in-line its overall industry.

BLCO Sales Forecast

Next quarter’s sales forecast for BLCO is $1.22B with a range of $1.20B to $1.25B. The previous quarter’s sales results were $1.41B. BLCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year BLCO has Performed in-line its overall industry.

BLCO Stock Forecast FAQ

What is BLCO’s average 12-month price target, according to analysts?

Based on analyst ratings, Bausch + Lomb Corporation’s 12-month average price target is 18.82.

What is BLCO’s upside potential, based on the analysts’ average price target?

Bausch + Lomb Corporation has 4.90% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BLCO a Buy, Sell or Hold?

Bausch + Lomb Corporation has a consensus rating of Hold which is based on 4 buy ratings, 7 hold ratings and 1 sell ratings.

What is Bausch + Lomb Corporation’s price target?

The average price target for Bausch + Lomb Corporation is 18.82. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $21.00 ,the lowest forecast is $15.00. The average price target represents 4.90% Increase from the current price of $17.94.

What do analysts say about Bausch + Lomb Corporation?

Bausch + Lomb Corporation’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of BLCO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Bausch + Lomb Corporation (BLCO) Stock Forecast & Price Target

BLCO Analyst Ratings

BLCO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Bausch + Lomb Corporation

BLCO Analyst Recommendation Trends

BLCO Financial Forecast

BLCO Earnings Forecast

BLCO Sales Forecast

BLCO Stock Forecast FAQ

Detailed List of Analyst Forecasts